Azenta, Inc.
Health
Performance
8.2
Risk
Sell
Buy
Curious about the Scores? Learn more.

Azenta, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

05.02.2026
Rock bottom. The fall’s complete, stability nowhere to be found.
05.02.2026
Red alert. Risk levels out of control.
20.08.2025
Pulse detected. Still fragile, but stabilizing.
AZTA
Azenta, Inc.
30.45
+1.53%
8.2
Sell
Buy
Azenta, Inc.

Azenta, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Azenta, Inc. do? Business model and key facts

Get the full picture of Azenta, Inc.: what it builds, where it operates, and how it makes money.

Azenta, Inc. Profile

Sector: Healthcare

Industry: Medical - Instruments & Supplies

Employees (FY): 3000

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

shop
Company facts
John Marotta
CEO
3000
Employees worldwide
shop
Performance
-33.6%
Last 12 months
-65.5%
Last 5 years
shop
Growth
$593,82M
Revenue year
$-59.503.000
Net income
shop
Valuation
$1,40B
Market Cap
-22.08
Price/Earnings Ratio

Stocks related to Azenta, Inc.

Selected based on industry alignment and relative market positioning.

ATRC
AtriCure, Inc.
32.90
-13.05%
6.2
Sell
Buy
AtriCure, Inc.
LMAT
LeMaitre Vascular, Inc.
87.78
-0.22%
4.7
Sell
Buy
LeMaitre Vascular, Inc.
WRBY
Warby Parker Inc.
21.99
-2.27%
9.5
Sell
Buy
Warby Parker Inc.
NVCR
NovoCure Limited
10.50
+0.29%
8.2
Sell
Buy
NovoCure Limited
STAA
STAAR Surgical Company
17.25
-0.29%
8.7
Sell
Buy
STAAR Surgical Company

Azenta, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.